Form 4: Mirum Pharmaceuticals COO Peter Radovich Sells Shares
SEC Form 4 Filing
Peter Radovich, President and COO of Mirum Pharmaceuticals, Inc., sold shares of common stock on March 4, 2025.
Summary
- On March 4, 2025, Peter Radovich, the President and COO of Mirum Pharmaceuticals, Inc. (MIRM), sold 13,681 shares of common stock at a weighted average price of $45.5711.
- He also sold 1,169 shares of common stock at $45.74.
- Following these transactions, Radovich directly owns 12,111 shares of Mirum Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment, but the sales themselves could be interpreted in various ways depending on the context.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders buy or sell their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- Shareholders may interpret the stock sale as a lack of confidence in the company's future prospects, although there could be various personal financial reasons for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of stock sale transactions |
| 03/05/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.